标题
Minimal residual disease testing in hematologic malignancies and solid cancer
作者
关键词
-
出版物
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
Volume 14, Issue 6, Pages 699-712
出版商
Informa UK Limited
发表日期
2014-06-18
DOI
10.1586/14737159.2014.927311
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Chronic Myelogenous Leukemia
- (2017) Susan O'Brien et al. Journal of the National Comprehensive Cancer Network
- Interpretation of Changes in Circulating Tumor Cell Counts
- (2014) Frank A.W. Coumans et al. Translational Oncology
- European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013
- (2013) M. Baccarani et al. BLOOD
- Establishment and Validation of Analytical Reference Panels for the Standardization of Quantitative BCR-ABL1 Measurements on the International Scale
- (2013) H. E. White et al. CLINICAL CHEMISTRY
- Deregulated Serum Concentrations of Circulating Cell-Free MicroRNAs miR-17, miR-34a, miR-155, and miR-373 in Human Breast Cancer Development and Progression
- (2013) C. Eichelser et al. CLINICAL CHEMISTRY
- Should evaluation for minimal residual disease be routine in acute myeloid leukemia?
- (2013) Elaine Coustan-Smith et al. CURRENT OPINION IN HEMATOLOGY
- BCR-ABL1 RT-qPCR for Monitoring the Molecular Response to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia
- (2013) Richard D. Press et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- What does MRD in leukemia really mean?
- (2013) J M Goldman et al. LEUKEMIA
- The role of different genetic subtypes of CEBPA mutated AML
- (2013) A Fasan et al. LEUKEMIA
- Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) study
- (2013) J V Jovanovic et al. LEUKEMIA
- Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
- (2013) Muhammed Murtaza et al. NATURE
- Minimal residual disease in acute myeloid leukaemia
- (2013) Christopher S. Hourigan et al. Nature Reviews Clinical Oncology
- Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2
- (2013) J. Nangalia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms
- (2013) Thorsten Klampfl et al. NEW ENGLAND JOURNAL OF MEDICINE
- Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
- (2013) Sarah-Jane Dawson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Defining consensus leukemia-associated immunophenotypes for detection of minimal residual disease in acute myeloid leukemia in a multicenter setting
- (2013) N Feller et al. Blood Cancer Journal
- The changing paradigm of prognostic factors in acute myeloid leukaemia
- (2012) David Grimwade BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Evaluation of Minimal Residual Disease by Real-Time Quantitative PCR of Wilms’ Tumor 1 Expression in Patients with Acute Myelogenous Leukemia after Allogeneic Stem Cell Transplantation: Correlation with Flow Cytometry and Chimerism
- (2012) Mi Kwon et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemia
- (2012) A. F. T. Ribeiro et al. BLOOD
- Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group Study
- (2012) I.-M. Chen et al. BLOOD
- Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: a single-institution historical experience
- (2012) H. Kantarjian et al. BLOOD
- Deep-sequencing approach for minimal residual disease detection in acute lymphoblastic leukemia
- (2012) M. Faham et al. BLOOD
- Recent advances in acute myeloid leukemia stem cell biology
- (2012) S. J. Horton et al. HAEMATOLOGICA
- Molecular markers in acute myeloid leukaemia
- (2012) Andrea Kühnl et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Considerations in the development of circulating tumor cell technology for clinical use
- (2012) David R Parkinson et al. Journal of Translational Medicine
- Flow cytometry and IG/TCR quantitative PCR for minimal residual disease quantitation in acute lymphoblastic leukemia: a French multicenter prospective study on behalf of the FRALLE, EORTC and GRAALL
- (2012) R Garand et al. LEUKEMIA
- Improved flow cytometric detection of minimal residual disease in childhood acute lymphoblastic leukemia
- (2012) B Denys et al. LEUKEMIA
- DNMT3A mutations in acute myeloid leukemia: stability during disease evolution and clinical implications
- (2011) H.-A. Hou et al. BLOOD
- Circulating Tumor Cell Isolation and Diagnostics: Toward Routine Clinical Use
- (2011) A. van de Stolpe et al. CANCER RESEARCH
- Minimal residual disease in solid neoplasia: New frontier or red-herring?
- (2011) Pierre Mordant et al. CANCER TREATMENT REVIEWS
- Monitoring of Minimal Residual Disease in Acute Myeloid Leukemia: Methods and Best Applications
- (2011) Jeffrey L. Jorgensen et al. Clinical Lymphoma Myeloma & Leukemia
- NPM1 mutation is a stable marker for minimal residual disease monitoring in acute myeloid leukaemia patients with increased sensitivity compared to WT1 expression*
- (2011) Thomas Kristensen et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Development of standardized approaches to reporting of minimal residual disease data using a reporting software package designed within the European LeukemiaNet
- (2011) M Østergaard et al. LEUKEMIA
- Minimal residual disease monitoring based on FLT3 internal tandem duplication in adult acute myeloid leukemia
- (2011) Emna Abdelhamid et al. LEUKEMIA RESEARCH
- High-throughput VDJ sequencing for quantification of minimal residual disease in chronic lymphocytic leukemia and immune reconstitution assessment
- (2011) A. C. Logan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Concise Review: Cancer Stem Cells and Minimal Residual Disease
- (2011) Gabriel Ghiaur et al. STEM CELLS
- Minimal Residual Disease in Acute Lymphoblastic Leukemia
- (2011) D. Campana Hematology-American Society of Hematology Education Program
- Leukemia stem cells
- (2010) Ugo Testa ANNALS OF HEMATOLOGY
- Presence of the P2RY8-CRLF2 rearrangement is associated with a poor prognosis in non-high-risk precursor B-cell acute lymphoblastic leukemia in children treated according to the ALL-BFM 2000 protocol
- (2010) G. Cario et al. BLOOD
- Establishment of the first World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL mRNA
- (2010) H. E. White et al. BLOOD
- The prognostic and functional role of microRNAs in acute myeloid leukemia
- (2010) G. Marcucci et al. BLOOD
- Impact of JAK2V617F mutation status, allele burden, and clearance after allogeneic stem cell transplantation for myelofibrosis
- (2010) H. Alchalby et al. BLOOD
- Screening and monitoring of MPL W515L mutation with real-time PCR in patients with myelofibrosis undergoing allogeneic-SCT
- (2010) H Alchalby et al. BONE MARROW TRANSPLANTATION
- Monitoring molecular response in chronic myeloid leukemia
- (2010) Jorge Cortes et al. CANCER
- Circulating tumor cells as a surrogate marker for determining response to chemotherapy in patients with advanced gastric cancer
- (2010) Satoshi Matsusaka et al. CANCER SCIENCE
- Detection and HER2 Expression of Circulating Tumor Cells: Prospective Monitoring in Breast Cancer Patients Treated in the Neoadjuvant GeparQuattro Trial
- (2010) S. Riethdorf et al. CLINICAL CANCER RESEARCH
- Insights into minimal residual disease in cancer patients: Implications for anti-cancer therapies
- (2010) Volkmar Müller et al. EUROPEAN JOURNAL OF CANCER
- DNMT3AMutations in Acute Myeloid Leukemia
- (2010) Timothy J. Ley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)
- (2009) R. Bassan et al. BLOOD
- Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK-19/mammaglobin RT–PCR in patients with metastatic breast cancer
- (2009) I Van der Auwera et al. BRITISH JOURNAL OF CANCER
- Clinical significance of minimal residual disease at day 15 and at the end of therapy in childhood acute lymphoblastic leukaemia
- (2009) Rosemary Sutton et al. BRITISH JOURNAL OF HAEMATOLOGY
- Minimal residual disease is a significant predictor of treatment failure in non T-lineage adult acute lymphoblastic leukaemia: final results of the international trial UKALL XII/ECOG2993
- (2009) Bella Patel et al. BRITISH JOURNAL OF HAEMATOLOGY
- Role of Minimal Residual Disease Monitoring in Adult and Pediatric Acute Lymphoblastic Leukemia
- (2009) Dario Campana HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Risk of Relapse of Childhood Acute Lymphoblastic Leukemia Is Predicted By Flow Cytometric Measurement of Residual Disease on Day 15 Bone Marrow
- (2009) Giuseppe Basso et al. JOURNAL OF CLINICAL ONCOLOGY
- Real-Time Quantitative Polymerase Chain Reaction Detection of Minimal Residual Disease by StandardizedWT1Assay to Enhance Risk Stratification in Acute Myeloid Leukemia: A European LeukemiaNet Study
- (2009) Daniela Cilloni et al. JOURNAL OF CLINICAL ONCOLOGY
- Pegylated Interferon Alfa-2a Yields High Rates of Hematologic and Molecular Response in Patients With Advanced Essential Thrombocythemia and Polycythemia Vera
- (2009) Alfonso Quintás-Cardama et al. JOURNAL OF CLINICAL ONCOLOGY
- Prospective Minimal Residual Disease Monitoring to Predict Relapse of Acute Promyelocytic Leukemia and to Direct Pre-Emptive Arsenic Trioxide Therapy
- (2009) David Grimwade et al. JOURNAL OF CLINICAL ONCOLOGY
- Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data
- (2009) Howard I Scher et al. LANCET ONCOLOGY
- Standardized MRD quantification in European ALL trials: Proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18–20 September 2008
- (2009) M Brüggemann et al. LEUKEMIA
- Rearrangement of CRLF2 in B-progenitor– and Down syndrome–associated acute lymphoblastic leukemia
- (2009) Charles G Mullighan et al. NATURE GENETICS
- Incidence, Sensitivity, and Specificity of Leukemia-Associated Phenotypes in Acute Myeloid Leukemia Using Specific Five-Color Multiparameter Flow Cytometry
- (2008) Adhra Al-Mawali et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy: long-term outcome of the LPA 99 multicenter study by the PETHEMA Group
- (2008) M. A. Sanz et al. BLOOD
- Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera
- (2008) J.-J. Kiladjian et al. BLOOD
- Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet
- (2008) M. A. Sanz et al. BLOOD
- Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials
- (2008) S. Branford et al. BLOOD
- Safety and efficacy of imatinib in chronic eosinophilic leukaemia and hypereosinophilic syndrome - a phase-II study
- (2008) Georgia Metzgeroth et al. BRITISH JOURNAL OF HAEMATOLOGY
- Molecular monitoring in chronic myeloid leukemia
- (2008) Elias Jabbour et al. CANCER
- Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
- (2008) J. S. de Bono et al. CLINICAL CANCER RESEARCH
- Monitoring treatment of chronic myeloid leukemia
- (2008) M. Baccarani et al. HAEMATOLOGICA
- Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic Colorectal Cancer
- (2008) Steven J. Cohen et al. JOURNAL OF CLINICAL ONCOLOGY
- Development of Minimal Residual Disease–Directed Therapy in Acute Myeloid Leukemia
- (2008) Sylvie D. Freeman et al. SEMINARS IN ONCOLOGY
- International standardisation of quantitative real-time RT-PCR for BCR-ABL
- (2007) Nicholas C.P. Cross et al. LEUKEMIA RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now